IL107303A - Ranitidine compositions, their preparation and pharmaceutical compositions comprising them - Google Patents

Ranitidine compositions, their preparation and pharmaceutical compositions comprising them

Info

Publication number
IL107303A
IL107303A IL107303A IL10730393A IL107303A IL 107303 A IL107303 A IL 107303A IL 107303 A IL107303 A IL 107303A IL 10730393 A IL10730393 A IL 10730393A IL 107303 A IL107303 A IL 107303A
Authority
IL
Israel
Prior art keywords
ranitidine
lipid
particles
composition
physiologically acceptable
Prior art date
Application number
IL107303A
Other languages
English (en)
Other versions
IL107303A0 (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929221800A external-priority patent/GB9221800D0/en
Priority claimed from GB929221760A external-priority patent/GB9221760D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL107303A0 publication Critical patent/IL107303A0/xx
Publication of IL107303A publication Critical patent/IL107303A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Saccharide Compounds (AREA)
IL107303A 1992-10-16 1993-10-15 Ranitidine compositions, their preparation and pharmaceutical compositions comprising them IL107303A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929221800A GB9221800D0 (en) 1992-10-16 1992-10-16 Pharmaceutical compositions
GB929221760A GB9221760D0 (en) 1992-10-16 1992-10-16 Medicaments

Publications (2)

Publication Number Publication Date
IL107303A0 IL107303A0 (en) 1994-01-25
IL107303A true IL107303A (en) 1998-02-08

Family

ID=26301808

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107303A IL107303A (en) 1992-10-16 1993-10-15 Ranitidine compositions, their preparation and pharmaceutical compositions comprising them

Country Status (12)

Country Link
US (1) US5635200A (zh)
EP (1) EP0664701B1 (zh)
JP (1) JPH08510989A (zh)
CN (1) CN1052877C (zh)
AT (1) ATE157867T1 (zh)
AU (1) AU669952B2 (zh)
CA (1) CA2146999A1 (zh)
DE (1) DE69313865T2 (zh)
ES (1) ES2107685T3 (zh)
IL (1) IL107303A (zh)
MX (1) MX9306393A (zh)
WO (1) WO1994008576A1 (zh)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08511559A (ja) * 1993-06-18 1996-12-03 スミスクライン・ビーチャム・コーポレイション 軟外皮ゼラチンに封入された粒子
MY111346A (en) * 1993-07-09 1999-11-30 Smithkline Beecham Corp Soft-shelled gelatin encapsulated particles
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
DK171127B1 (da) * 1994-04-22 1996-06-24 Gea Farmaceutisk Fabrik As Ranitidintablet med et hydroxypropylmethylcelluloseholdigt overtræk samt fremgangsmåde til at tilvejebringe dette overtræk
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
AU718160B2 (en) 1995-06-09 2000-04-06 R.P. Scherer Corporation Soft gelatin capsules containing particulate material
US5706830A (en) * 1996-05-06 1998-01-13 South Alabama Medical Science Foundation Liquid ventilator system and use thereof
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
EP1007012A4 (en) * 1996-10-01 2006-01-18 Cima Labs Inc TASTE-MASKED MICRO-CAPSULE COMPOSITION AND MANUFACTURING PROCESS
US6242019B1 (en) * 1997-08-14 2001-06-05 Warner-Lambert Company Taste modified hard confectionery compositions containing functional ingredients
NZ503086A (en) 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
GB9806477D0 (en) * 1998-03-26 1998-05-27 Glaxo Group Ltd Improved crystals
GB9819272D0 (en) * 1998-09-03 1998-10-28 Andaris Ltd Microparticles
JP2002179560A (ja) * 1999-02-26 2002-06-26 Shionogi & Co Ltd 服用性を改良した咀嚼型ソフトカプセル剤およびその製法
CA2363842C (en) * 1999-02-26 2006-01-10 Shionogi & Co., Ltd. Chewable soft capsule having improved ingestion property and method for producing the same
US6794411B1 (en) 1999-04-06 2004-09-21 Laboratoire Des Produits Ethiques Ethypharm Drinkable ibuprofen pharmaceutical suspension
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
HRP20020124A2 (en) * 2002-02-11 2003-10-31 Pliva D D Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
AU2003209673B2 (en) * 2002-03-08 2007-10-18 M/S. Ind-Swift Limited Tasteless directly compressible fast-dissolving complexes and pharmaceutical formulations thereof
US20040096498A1 (en) * 2002-04-29 2004-05-20 Alvin Kershman Oral pharmaceutical delivery system with improved sustained release
WO2004016247A1 (en) * 2002-08-14 2004-02-26 E.I. Du Pont De Nemours And Company Process for coating a pharmaceutical particle
US20040146553A1 (en) 2002-12-23 2004-07-29 Aventis Pharma S.A. Compositions for oral administration of active principles requiring masking of taste
FR2848855B1 (fr) * 2002-12-23 2005-02-11 Aventis Pharma Sa Compositions pour administration orale de principes actifs necessitant un masquage du gout
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20060233873A1 (en) * 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20040185170A1 (en) * 2003-03-21 2004-09-23 Shubha Chungi Method for coating drug-containing particles and formulations and dosage units formed therefrom
AU2003300694A1 (en) * 2003-04-17 2004-11-04 Ipca Laboratories Limited Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them
US8545881B2 (en) 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture
ITMI20041820A1 (it) * 2004-09-24 2004-12-24 Ascor Chimici Srl Composizione in micro-pellets a rilascio controllato di sostanze fisiologicamente attive, procedimento di preparazione e relativo impiego nel settore zootecnico.
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP1802285B1 (en) 2004-10-21 2013-02-27 Aptalis Pharmatech, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
TWI471146B (zh) 2009-12-02 2015-02-01 Aptalis Pharma Ltd 菲索特芬那定（ｆｅｘｏｆｅｎａｄｉｎｅ）微膠囊及包含其之組合物
JP5609105B2 (ja) * 2009-12-24 2014-10-22 ライオン株式会社 ラニチジン含有被覆粒子及びその製造方法
FR2959130A1 (fr) * 2010-04-21 2011-10-28 Sanofi Aventis Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant.
WO2014135967A1 (en) 2013-03-06 2014-09-12 Capsugel Belgium Nv Curcumin solid lipid particles and methods for their preparation and use
US20170112762A1 (en) * 2014-06-10 2017-04-27 Capsugel Belgium Nv Orally disintegrating tablet containing solid lipid particles and methods for their preparation and use
US11324699B2 (en) 2014-12-04 2022-05-10 Capsugel Belgium Nv Lipid multiparticulate formulations
CN105030694A (zh) * 2015-08-04 2015-11-11 青岛蓝盛洋医药生物科技有限责任公司 一种治疗胃溃疡的药物盐酸雷尼替丁组合物干混悬剂
US11433024B2 (en) 2018-04-27 2022-09-06 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3777721D1 (de) * 1986-08-11 1992-04-30 American Cyanamid Co Zusammensetzungen zur parenteralen verabreichung und deren verwendung.
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
US5219563A (en) * 1988-05-11 1993-06-15 Glaxo Group Limited Drug adsorbates
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
US5275823A (en) * 1989-04-27 1994-01-04 Smith Kline & French Laboratories Ltd. Pharmaceutical compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
EP0421581A1 (en) * 1989-10-03 1991-04-10 Warner-Lambert Company Chewable spray dried spheroidal microcapsules and wax coated microcapsules and methods for preparing same
US5290569A (en) * 1990-04-12 1994-03-01 Shionogi & Co., Ltd. Coated composition and its preparation process
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
JPH06501003A (ja) * 1990-09-13 1994-01-27 スミスクライン・ビーチャム・コーポレイション 非水性液状経口懸濁液
FI922107A0 (fi) * 1991-05-10 1992-05-08 Faulding F H & Co Ltd Mikrokapselkomposition och foerfarande.
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
CA2103443C (en) * 1991-05-28 1998-12-22 Robert P. Geyer Chewable drug-delivery composition
US5429825A (en) * 1992-06-26 1995-07-04 Mcneil-Ppc, Inc. Rotomelt granulation

Also Published As

Publication number Publication date
WO1994008576A1 (en) 1994-04-28
MX9306393A (es) 1994-04-29
US5635200A (en) 1997-06-03
CN1092648A (zh) 1994-09-28
AU5333694A (en) 1994-05-09
EP0664701A1 (en) 1995-08-02
DE69313865D1 (de) 1997-10-16
ES2107685T3 (es) 1997-12-01
JPH08510989A (ja) 1996-11-19
CN1052877C (zh) 2000-05-31
IL107303A0 (en) 1994-01-25
DE69313865T2 (de) 1998-02-12
AU669952B2 (en) 1996-06-27
ATE157867T1 (de) 1997-09-15
EP0664701B1 (en) 1997-09-10
CA2146999A1 (en) 1994-04-28

Similar Documents

Publication Publication Date Title
AU669952B2 (en) Taste-masking compositions of ranitidine
KR0168715B1 (ko) 맛을 차단하는 약제학적 조성물
US6214386B1 (en) Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
EP0411952B1 (en) Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
KR950009097B1 (ko) 세푸록심 악세틸을 함유하는 제약 조성물
US6475510B1 (en) Process for manufacturing bite-dispersion tablets
ES2399898T3 (es) Composiciones farmacéuticas de sabor enmascarado preparadas por coacervación
KR101119850B1 (ko) 구강내 속붕해성 정제용 조성물
EP1001748B1 (en) A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets
US5260072A (en) Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
EP2560613B1 (en) Fexofenadine-based composition and preparation process therefor
JPH08503482A (ja) 部分水素添加植物油で被覆されたシメチジン顆粒剤
JP2005506323A (ja) 経口送達用機能性散剤
KR20060012576A (ko) 활성 성분의 전달을 위한 신규한 갈레누스 시스템, 제조방법 및 용도
JPH04270216A (ja) 味覚、テクスチャーおよび圧縮性が改良された環状アミノ酸デリバリーシステム
EP0862421B1 (en) Prompt-release pharmaceutical compositions
JP2008525389A (ja) 活性成分移送のための新規ガレン製剤系、その製造方法および用途
EP0473431B1 (en) Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
MXPA00006094A (en) Process for manufacturing bite-dispersion tablets
Sah et al. MOUTH DISSOLVING TABLET: A BETTER APPROACH TO DRUG DELIVERY

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
FF Patent granted
KB Patent renewed
RH1 Patent not in force